Skip to main content

Transforming the understanding
and treatment of mental illnesses.

Event Summaries about HIV/AIDS

Neurologic and Psychiatric Effects of SARS-CoV-2 Meeting

Date/Time: -

Location: Virtual

Description: The NIMH, National Institute of Neurological Disorders and Stroke, and National Institute on Aging are conducting a virtual meeting on the neurologic and psychiatric effects of SARS-CoV-2 infection from July 14-15, 2021.

Virtual Workshop: HIV-Related Intersectional Stigma Research Advances and Opportunities (HIVIS) Post-Workshop Deliverables

Date/Time: -

Location: Webinar

Description: On July 13, the National Institute of Mental Health held a virtual meeting to help promote HIV prevention and treatment science, as well as inform the Ending the HIV Epidemic initiative (EHE) and HIV efforts worldwide through furthering HIV-related intersectional stigma and discrimination research advances and opportunities.

Strengthening the Research Workforce of Latina/Hispanic Female Investigators to Address HIV Contextual Factors Affecting Women with HIV

Date/Time:

Location: San Diego, CA; Pre-Conference Learning Institute at American Public Health Association Annual Meeting

Description: The NIMH Division of AIDS Research hosted a meeting to address diversity mentoring programs to strengthen the HIV research workforce of Latina/Hispanic female investigators with added focus to address contextual factors affecting women living with HIV.

Neuroimaging in HIV: Novel Imaging Technologies for Detection of Persistent HIV and Associated Inflammation/Pathology in the Brain

Date/Time:

Location: Rockville, MD

Description: The NIMH Division of AIDS Research hosted a workshop to discuss the novel imaging technologies that can be used to detect persistent HIV in the central nervous system (CNS) as well as understand the pathways and mechanisms leading to CNS dysfunction in the antiretroviral therapy era.

Sponsored by: NIMH Division of AIDS Research

Anti-Retroviral Therapy-Mediated Mental Health Side Effects Workshop

Date/Time:

Location: Rockville, MD

Description: The NIMH Division of AIDS Research convened a workshop focused on the neuropsychiatric side effects of Antiretroviral Therapy (ART), and the potential for ART-mediated neurological toxicity when used across the lifespan of HIV.

Sponsored by: NIMH Division of AIDS Research

NeuroHIV in the ART era

Date/Time: -

Location: Bethesda, MD

Description: Despite the effectiveness of Anti-retroviral therapy (ART), HIV-induced CNS dysfunction persists, but a significant heterogeneity in the prevalence and severity of these disturbances still exist. Brain autopsy findings from HIV positive individuals on ART have revealed a paucity of the distinctive pathologic findings seen in the pre-ART era.

Sponsored by: NIMH Division of AIDS Research

Approach to Consortium Studies of CNS HIV Escape

Date/Time: -

Location: Pollenzo, Italy

Description: The NIMH Division of AIDS Research sponsored a session on “Approach to Consortium Studies of CNS HIV Escape” that was held in conjunction with the Seventh International Meeting on HIV infection in the CNS.

Sponsored by: NIMH Division of AIDS Research

Blood– brain barrier and HIV reservoirs in the CNS—formation and eradication

Date/Time: -

Location: Krakow, Poland

Description: The NIMH Division of AIDS Research hosted a session entitled “Blood– brain barrier and HIV reservoirs in the CNS—formation and eradication” in conjunction with the 20th International Symposium on Signal Transduction at the Blood–Brain Barriers.

Sponsored by: NIMH Division of AIDS Research

HIV PrEP Implementation Science Administrative Supplement Meeting

Date/Time:

Location: Bethesda, MD

Description: The NIMH Division of AIDS Research sponsored a meeting to advance the science of HIV pre-exposure prophylaxis (PrEP) implementation.

Innovative Measures of Medication Adherence for HIV Treatment and Prevention

Date/Time: -

Location: Rockville, MD

Description: The NIMH Division of AIDS Research co-sponsored a meeting with the National Institute of Allergy and Infectious Diseases (NIAID) to advance the next-generation of HIV medication adherence.